Emmaus Life Sciences Inc (EMMA)
US Market

Emmaus Life Sciences (EMMA) Income Statement


Emmaus Life Sciences Income Statement

Last quarter (Q2 2023), Emmaus Life Sciences's total revenue was $10.76M, an increase of 150.97% from the same quarter last year. In Q2, Emmaus Life Sciences's net income was $-1.48M. See Emmaus Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Sep 18
Total Revenue
$ 28.38M$ 18.39M$ 20.61M$ 23.17M$ 22.75M$ 1.32M
Cost of Revenue
$ 832.00K$ 2.59M$ 3.31M$ 2.25M$ 1.09M$ 827.40K
Gross Profit
$ 26.26M$ 15.80M$ 17.30M$ 20.92M$ 21.66M$ 488.10K
Operating Expense
$ 12.77M$ 22.39M$ 23.43M$ 20.95M$ 26.17M$ 10.73M
Operating Income
$ 3.03M$ -6.59M$ -6.13M$ -32.00K$ -4.51M$ -10.24M
Net Non Operating Interest Income Expense
$ -8.22M$ -4.33M$ -2.34M$ -5.19M$ -27.39M$ -86.30K
Other Income Expense
$ 3.38M$ -3.16M$ -7.45M$ 6.19M$ -22.77M-
Pretax Income
$ -5.20M$ -10.56M$ -15.92M$ 973.00K$ -54.68M$ -10.33M
Tax Provision
$ -4.00K$ 60.00K$ 25.00K$ -381.00K$ 164.00K$ 1.90K
Earnings From Equity Interest Net Of Tax
$ -1.39M$ -1.91M----
Net Income Common Stockholders
$ -2.12M$ -10.62M$ -15.95M$ 1.35M$ -54.84M$ -9.60M
Basic EPS
$ -0.13$ -0.21$ -0.32$ 0.02$ -1.30$ -11.16
Diluted EPS
$ -0.10$ -0.21$ -0.32$ 0.02$ -1.30$ -11.16
Basic Average Shares
$ 202.57M$ 49.44M$ 49.25M$ 48.90M$ 42.26M$ 866.60K
Diluted Average Shares
$ 202.57M$ 49.44M$ 49.25M$ 48.90M$ 42.26M$ 866.60K
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 13.60M$ 24.98M$ 26.74M$ 23.20M$ 27.26M$ 11.56M
Net Income From Continuing And Discontinued Operation
$ -2.09M$ -10.60M$ -15.95M$ 1.35M$ -54.84M$ -9.60M
Normalized Income
$ -3.79M-$ -12.50M$ -4.67M$ -40.96M$ -9.60M
Interest Expense
$ 1.52M-$ 3.10M$ 5.99M$ 27.39M-
$ 3.37M$ -5.55M$ -12.82M$ 6.96M$ -27.29M$ -10.24M
$ 5.19M$ -3.68M$ -12.76M$ 7.02M$ -27.21M$ -10.13M
Currency in USD

Emmaus Life Sciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis